^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    cetuximab biosimilar

    Associations
    News

    Trials

    Company:
    CinnaGen
    Drug class:
    EGFR inhibitor
    Related drugs:
    Associations
    News

    Trials

    Apply
    Comparing Efficacy and Safety of Cetuximab (CinnaGen) Versus Erbitux® (Merck) in Metastatic Colorectal Cancer (NCT03391934)
    Phase 3
    Cinnagen
    Recruiting
    Last update posted :
    04/05/2023
    Initiation :
    01/20/2018
    Primary completion :
    11/30/2025
    Completion :
    02/01/2026
    EGFR • RAS
    |
    EGFR expression • RAS wild-type
    |
    Erbitux (cetuximab) • 5-fluorouracil • irinotecan • leucovorin calcium • cetuximab biosimilar